2021 ICD-10-CM Diagnosis Code R87.61

Abnormal cytological findings in specimens from cervix uteri

    2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
  • R87.61 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2021 edition of ICD-10-CM R87.61 became effective on October 1, 2020.
  • This is the American ICD-10-CM version of R87.61 - other international versions of ICD-10 R87.61 may differ.
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as R87.61. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • abnormal cytological findings in specimens from other female genital organs (
    ICD-10-CM Diagnosis Code R87.69

    Abnormal cytological findings in specimens from other female genital organs

      2016 2017 2018 2019 2020 2021 Billable/Specific Code
    Applicable To
    • Abnormal cytological findings in specimens from female genital organs NOS
    Type 1 Excludes
    • dysplasia of vulva (histologically confirmed) (N90.0-N90.3)
    R87.69
    )
  • abnormal cytological findings in specimens from vagina (
    ICD-10-CM Diagnosis Code R87.62

    Abnormal cytological findings in specimens from vagina

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from cervix uteri (R87.61-)
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • carcinoma in situ of vagina (histologically confirmed) (D07.2)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    Type 2 Excludes
    • vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
    • vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)
    Use Additional
    • code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)
    R87.62-
    )
  • carcinoma in situ of cervix uteri (histologically confirmed) (
    ICD-10-CM Diagnosis Code D06
    • D06 Carcinoma in situ of cervix uteri
      • D06.0 Carcinoma in situ of endocervix
      • D06.1 Carcinoma in situ of exocervix
      • D06.7 Carcinoma in situ of other parts of cervix
      • D06.9 Carcinoma in situ of cervix, unspecified
    D06.-
    )
  • cervical intraepithelial neoplasia I [CIN I] (
    ICD-10-CM Diagnosis Code N87.0

    Mild cervical dysplasia

      2016 2017 2018 2019 2020 2021 Billable/Specific Code
    Applicable To
    • Cervical intraepithelial neoplasia I [CIN I]
    N87.0
    )
  • cervical intraepithelial neoplasia II [CIN II] (
    ICD-10-CM Diagnosis Code N87.1

    Moderate cervical dysplasia

      2016 2017 2018 2019 2020 2021 Billable/Specific Code
    Applicable To
    • Cervical intraepithelial neoplasia II [CIN II]
    N87.1
    )
  • cervical intraepithelial neoplasia III [CIN III] (
    ICD-10-CM Diagnosis Code D06
    • D06 Carcinoma in situ of cervix uteri
      • D06.0 Carcinoma in situ of endocervix
      • D06.1 Carcinoma in situ of exocervix
      • D06.7 Carcinoma in situ of other parts of cervix
      • D06.9 Carcinoma in situ of cervix, unspecified
    D06.-
    )
  • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (
    ICD-10-CM Diagnosis Code N87
    • N87 Dysplasia of cervix uteri
      • N87.0 Mild cervical dysplasia
      • N87.1 Moderate cervical dysplasia
      • N87.9 Dysplasia of cervix uteri, unspecified
    N87.-
    )
  • severe dysplasia of cervix uteri (histologically confirmed) (
    ICD-10-CM Diagnosis Code D06
    • D06 Carcinoma in situ of cervix uteri
      • D06.0 Carcinoma in situ of endocervix
      • D06.1 Carcinoma in situ of exocervix
      • D06.7 Carcinoma in situ of other parts of cervix
      • D06.9 Carcinoma in situ of cervix, unspecified
    D06.-
    )
Type 2 Excludes
Type 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (R87.61) and the excluded code together.
  • cervical high risk human papillomavirus (HPV) DNA test positive (
    ICD-10-CM Diagnosis Code R87.810

    Cervical high risk human papillomavirus (HPV) DNA test positive

      2016 2017 2018 2019 2020 2021 Billable/Specific Code
    R87.810
    )
  • cervical low risk human papillomavirus (HPV) DNA test positive (
    ICD-10-CM Diagnosis Code R87.820

    Cervical low risk human papillomavirus (HPV) DNA test positive

      2016 2017 2018 2019 2020 2021 Billable/Specific Code
    R87.820
    )
The following code(s) above R87.61 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to R87.61:
  • R00-R99
    2021 ICD-10-CM Range R00-R99

    Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

    Note
    • This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
    • Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
    • The conditions and signs or symptoms included in categories R00-R94 consist of:
    • (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
    • (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
    • (c) provisional diagnosis in a patient who failed to return for further investigation or care;
    • (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
    • (e) cases in which a more precise diagnosis was not available for any other reason;
    • (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.
    Type 2 Excludes
    • abnormal findings on antenatal screening of mother (O28.-)
    • certain conditions originating in the perinatal period (P04-P96)
    • signs and symptoms classified in the body system chapters
    • signs and symptoms of breast (N63, N64.5)
    Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
  • R83-R89
    2021 ICD-10-CM Range R83-R89

    Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

    Type 1 Excludes
    • abnormal findings on antenatal screening of mother (O28.-)
    • diagnostic abnormal findings classified elsewhere - see Alphabetical Index
    Type 2 Excludes
    • abnormal findings on examination of blood, without diagnosis (R70-R79)
    • abnormal findings on examination of urine, without diagnosis (R80-R82)
    • abnormal tumor markers (R97.-)
    Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis
  • R87
    ICD-10-CM Diagnosis Code R87

    Abnormal findings in specimens from female genital organs

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Includes
    • abnormal findings in secretion and smears from cervix uteri
    • abnormal findings in secretion and smears from vagina
    • abnormal findings in secretion and smears from vulva
    Abnormal findings in specimens from female genital organs
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
Code annotations containing back-references to R87.61:
  • Type 1 Excludes: N87
    , R87.62
    ICD-10-CM Diagnosis Code N87

    Dysplasia of cervix uteri

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from cervical cytologic examination without histologic confirmation (R87.61-)
    • carcinoma in situ of cervix uteri (D06.-)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • HGSIL of cervix (R87.613)
    • severe dysplasia of cervix uteri (D06.-)
    ICD-10-CM Diagnosis Code R87.62

    Abnormal cytological findings in specimens from vagina

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from cervix uteri (R87.61-)
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • carcinoma in situ of vagina (histologically confirmed) (D07.2)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    Type 2 Excludes
    • vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
    • vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)
    Use Additional
    • code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)
ICD-10-CM Codes Adjacent To R87.61
R86.8 Other abnormal findings in specimens from male genital organs
R86.9 Unspecified abnormal finding in specimens from male genital organs
R87 Abnormal findings in specimens from female genital organs
R87.0 Abnormal level of enzymes in specimens from female genital organs
R87.1 Abnormal level of hormones in specimens from female genital organs
R87.2 Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs
R87.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs
R87.4 Abnormal immunological findings in specimens from female genital organs
R87.5 Abnormal microbiological findings in specimens from female genital organs
R87.6 Abnormal cytological findings in specimens from female genital organs
R87.61 Abnormal cytological findings in specimens from cervix uteri
R87.610 Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)
R87.611 Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)
R87.612 Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)
R87.613 High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)
R87.614 Cytologic evidence of malignancy on smear of cervix
R87.615 Unsatisfactory cytologic smear of cervix
R87.616 Satisfactory cervical smear but lacking transformation zone
R87.618 Other abnormal cytological findings on specimens from cervix uteri
R87.619 Unspecified abnormal cytological findings in specimens from cervix uteri
R87.62 Abnormal cytological findings in specimens from vagina

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.